28.03.2012 • News

CNOOC Says 2011 Profit Surges 29%

China's top offshore oil producer CNOOC posted a 29% rise in 2011 net profit on Wednesday, matching forecasts, on soaring crude oil prices.

Unlike peers PetroChina and China Petroleum & Chemical Corp (Sinopec) , CNOOC's profit comes solely from exploration and production, making it a key beneficiary of buoyant crude oil prices.

State-run CNOOC posted a net profit of 70.26 billion yuan ($11.14 billion) for 2011, compared with 54.41 billion yuan for the previous year.

The result was in line with a consensus forecast of 69.5 billion yuan from 33 analysts polled by Thomson Reuters I/B/E/S.

Valued at about $95 billion, CNOOC shares tumbled 26% in 2011, underperforming PetroChina's 4.8% loss, and Sinopec's 9.8% gain in Hong Kong in the same period.

CNOOC's 2011 output was hit hard by an oil spill at its Penglai 19-3 field in eastern China's Bohai bay, which resulted in total production losses of 5.9 million boe last year.

President and Chief Executive Li Fanrong said in January that the oilfield, co-owned and operated by ConocoPhillips, should resume production this year.

 

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read